|1.||Nambiar, Madhusoodana P: 2 articles (12/2008 - 07/2003)|
|2.||Krishnan, Sandeep: 2 articles (12/2008 - 07/2003)|
|3.||Fisher, Carolyn U: 2 articles (12/2008 - 07/2003)|
|4.||Tsokos, George C: 2 articles (12/2008 - 07/2003)|
|5.||Abe, Tohru: 2 articles (03/2005 - 09/2003)|
|6.||Takeuchi, Tsutomu: 2 articles (03/2005 - 09/2003)|
|7.||Tsuzaka, Kensei: 2 articles (03/2005 - 09/2003)|
|8.||Yoshimoto, Keiko: 2 articles (03/2005 - 09/2003)|
|9.||Setoyama, Yumiko: 2 articles (03/2005 - 09/2003)|
|10.||Suzuki, Katsuya: 2 articles (03/2005 - 09/2003)|
12/20/2005 - "Bound to tumor cells, r28M induced exceedingly efficient supraagonistic T-cell activation via the CD28 molecule without an additional stimulus via the TCR/CD3 complex. "
01/01/2004 - "Factor FAS and xi chain of TCR-CD3 complex take part in induction of apoptosis of lymphocyte which infiltrate neoplasm as well as lymphocytes of peripheral blood (PBL). "
11/01/2002 - "These results are consistent with the TCR serial triggering model and suggest that BscAb with extremely low affinity for the TCR-CD3 complex could be exploited therapeutically because of their preferential localization to tumor cells."
08/01/1995 - "Bifunctional Abs (BFA) with specificity for the TCR/CD3 complex of T cells and tumor Ag can bridge T lymphocytes and tumor cells and, thereby, trigger activation events. "
02/01/1994 - "Moreover, the lytic activity of these lines was blocked by anti-CD3 antibody, suggesting that tumor recognition was through the TCR/CD3 complex. "
|2.||Lead Poisoning (Poisoning, Lead)
03/01/2013 - "In order to study the feature of T cell TCR-CD3 complex-mediated gene in lead poisoning patients. "
03/01/2013 - "Expression of T cell TCR-CD3 complex-mediated gene was changed in lead poisoning patients, it might be related to the body immunodeficiency. "
03/01/2013 - "[Change of T cell TCR-CD3 complex-mediated gene expression pattern in lead poisoning patients]."
|3.||Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/01/2008 - "Diminished expression of TCR zeta and reciprocal up-regulation and association of FcRgamma with the TCR/CD3 complex is a hallmark of systemic lupus erythematosus (SLE) T cells. "
02/01/1999 - "Defective signal transduction via TCR-CD3 complex in patients with systemic lupus erythematosus."
08/15/1995 - "We studied the TCR/CD3 complex-mediated signal transduction pathway in freshly isolated T cells and T cell lines from patients with systemic lupus erythematosus (SLE). "
08/15/1995 - "TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus."
05/01/2004 - "Some of the signaling phenotypic abnormalities observed in peripheral blood T cells from patients with systemic lupus erythematosus resemble those seen in cells anergized by stimulation through the TCR/CD3 complex, in the absence of costimulatory signals, or by stimulation with altered ligands. "
|4.||T-Cell Lymphoma (Lymphoma, T Cell)
02/01/1998 - "Using human thymocytes, human peripheral blood lymphocytes and the rat Nb2 lymphoma T-cell, we found that PRL induced rapid phosphorylation of multiple, TCR/CD3 complex proteins, an event required for lymphocyte activation. "
12/01/1989 - "Cholera toxin modulates the T cell antigen receptor/CD3 complex but not the CD2 molecule and inhibits signaling via both receptor structures in the human T cell lymphoma Jurkat."
09/01/1991 - "We investigated the expression of the T cell receptor (TCR)/CD3 complex on a CD4-positive human T cell lymphoma cell line treated with phorbol myristate acetate (PMA) and/or CA2+ ionophore using fluorescence flow cytometry and fluorescence microscopic analysis. "
06/01/1991 - "Cholera toxin treatment of the human T cell lymphoma Jurkat resulted in inhibition of signalling via the T cell antigen receptor complex (TcR/CD3-complex). "
09/01/1990 - "The G protein coupling T cell antigen receptor/CD3-complex and phospholipase C in the human T cell lymphoma Jurkat is not a target for cholera toxin."
11/15/1991 - "Cell surface expression of the T-cell receptor (TCR)/CD3 complex on the cells from 11 acute type adult T-cell leukemia (ATL) and 4 lymphoma type ATL patients was examined by flow cytometry. "
01/15/1992 - "We investigated the mechanisms of anti-IgM antibody-induced cell death in a recently established human surface IgM+ IgD+ B lymphoma cell line, B104, the growth of which is irreversibly inhibited by anti-IgM antibody but not by anti-IgD antibody, and compared it with the cell death of T cells via TCR/CD3 complex and with the cell death of a murine anti-IgM antibody-sensitive B lymphoma cell line, WEHI-231. "
06/01/1994 - "These bispecific antibodies were hybrid-hybridoma antibodies with dual specificity for the TcR/CD3 complex and for the tumor-specific idiotype of the surface IgM expressed by the lymphoma cells. "
09/01/1992 - "To investigate whether CsA inhibits only the cell death through the signals via the TCR/CD3 complex or all of the programmed cell death induced by various reagents, we further established CD4+8+ thymic lymphomas which result in programmed cell death after activation with calcium ionophore, dexamethasone, cyclic AMP or anti-CD3 antibody. "
|2.||Immunoglobulin M (IgM)
|3.||T-Cell Antigen Receptors (T-Cell Receptor)
|7.||Messenger RNA (mRNA)
|9.||Indicators and Reagents (Reagents)
|10.||GATA3 Transcription Factor
|1.||Highly Active Antiretroviral Therapy (HAART)